These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8183424)

  • 1. The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.
    Scarr E; Wingerchuk DM; Juorio AV; Paterson IA
    Neurochem Res; 1994 Feb; 19(2):153-9. PubMed ID: 8183424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
    J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
    Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP
    Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine.
    Berry MD; Scarr E; Zhu MY; Paterson IA; Juorio AV
    Br J Pharmacol; 1994 Dec; 113(4):1159-66. PubMed ID: 7889269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.
    Paterson IA; Davis BA; Durden DA; Juorio AV; Yu PH; Ivy G; Milgram W; Mendonca A; Wu P; Boulton AA
    Neurochem Res; 1995 Dec; 20(12):1503-10. PubMed ID: 8789614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study.
    Fornai F; Chen K; Giorgi FS; Gesi M; Alessandri MG; Shih JC
    J Neurochem; 1999 Dec; 73(6):2434-40. PubMed ID: 10582603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selegiline on dopamine concentration in the striatum of a primate.
    Kaseda S; Nomoto M; Iwata S
    Brain Res; 1999 Jan; 815(1):44-50. PubMed ID: 9974121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective monoamine oxidase (MAO) inhibitors on conditioned avoidance responses (CAR) of rats.
    Timár J; Knoll B; Gyarmati Z; Knoll J
    Pol J Pharmacol Pharm; 1979; 31(4):251-60. PubMed ID: 523335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
    Treseder SA; Rose S; Summo L; Jenner P
    J Neural Transm (Vienna); 2003 Mar; 110(3):229-38. PubMed ID: 12658372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.